1. Home
  2. GILT vs SAGE Comparison

GILT vs SAGE Comparison

Compare GILT & SAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GILT
  • SAGE
  • Stock Information
  • Founded
  • GILT 1987
  • SAGE 2010
  • Country
  • GILT Israel
  • SAGE United States
  • Employees
  • GILT N/A
  • SAGE N/A
  • Industry
  • GILT Radio And Television Broadcasting And Communications Equipment
  • SAGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • GILT Technology
  • SAGE Health Care
  • Exchange
  • GILT Nasdaq
  • SAGE Nasdaq
  • Market Cap
  • GILT 400.3M
  • SAGE 474.6M
  • IPO Year
  • GILT 1993
  • SAGE 2014
  • Fundamental
  • Price
  • GILT $6.34
  • SAGE $8.04
  • Analyst Decision
  • GILT Strong Buy
  • SAGE Hold
  • Analyst Count
  • GILT 2
  • SAGE 19
  • Target Price
  • GILT $8.50
  • SAGE $9.88
  • AVG Volume (30 Days)
  • GILT 341.0K
  • SAGE 1.2M
  • Earning Date
  • GILT 05-07-2025
  • SAGE 04-24-2025
  • Dividend Yield
  • GILT N/A
  • SAGE N/A
  • EPS Growth
  • GILT 6.30
  • SAGE N/A
  • EPS
  • GILT 0.44
  • SAGE N/A
  • Revenue
  • GILT $305,448,000.00
  • SAGE $41,243,000.00
  • Revenue This Year
  • GILT $45.38
  • SAGE $100.39
  • Revenue Next Year
  • GILT $11.84
  • SAGE $70.86
  • P/E Ratio
  • GILT $14.87
  • SAGE N/A
  • Revenue Growth
  • GILT 14.79
  • SAGE N/A
  • 52 Week Low
  • GILT $4.04
  • SAGE $4.62
  • 52 Week High
  • GILT $8.05
  • SAGE $18.76
  • Technical
  • Relative Strength Index (RSI)
  • GILT 36.83
  • SAGE 53.42
  • Support Level
  • GILT $6.58
  • SAGE $7.99
  • Resistance Level
  • GILT $6.85
  • SAGE $8.81
  • Average True Range (ATR)
  • GILT 0.21
  • SAGE 0.32
  • MACD
  • GILT -0.06
  • SAGE 0.01
  • Stochastic Oscillator
  • GILT 12.00
  • SAGE 42.91

About GILT Gilat Satellite Networks Ltd.

Gilat Satellite Networks Ltd is a provider of satellite-based broadband communications. The company designs and manufactures ground-based satellite communications equipment and provides comprehensive solutions and end-to-end services. Its portfolio includes a cloud-based satellite network platform, very small aperture terminals (VSATs), amplifiers, high-speed modems, on-the-move antennas and high-power solid-state power amplifiers (SSPAs), block-up converters (BUCs) and Transceivers. The company's solutions support multiple applications with a full portfolio of products to address key applications including broadband access, cellular backhaul, enterprise, in-flight connectivity, maritime, trains, defense, and public safety.

About SAGE Sage Therapeutics Inc.

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

Share on Social Networks: